Pure Global
NCT06414564

Effects of AHCL Insulin Pump on Glycemic Control and Psychosocial Outcomes in Pediatric Patients With Type 1 Diabetes

Effects of Advanced Hybrid Closed-loop System on Glycemic Control and Psychosocial Outcomes in Pediatric Patients With Type 1 Diabetes
Seoul National University Hospital·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Type 1 Diabetes
Drug/Device/Intervention
Medtronic 780G insulin pump
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Seoul National University Hospital
Location
Seoul, South Korea
Timeline & enrollment
Phase
N/A
Start date
Feb 01, 2024
End date
Dec 31, 2025
Enrollment
30 participants
Primary outcome

Time In Range (TIR)

Summary

Prospective, non-randomized, single-arm clinical trial to investigate the effects of advanced
 hybrid close-loop (AHCL) system insulin pump in pediatric patients with type 1 diabetes

ICD-10 classifications
Type 1 diabetes mellitusType 1 diabetes mellitus without complicationsType 1 diabetes mellitus with unspecified complicationsType 1 diabetes mellitus with other specified complicationsType 1 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06414564
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06414564 through Pure Global AI's free database. This phase not specified trial is sponsored by Seoul National University Hospital and is currently Recruiting. The study focuses on Type 1 Diabetes. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.